EW-7197, transforming growth factor β inhibitor, combined with irreversible electroporation for improving skin wound in a rat excisional model

MLA

Chu Hui Zeng, et al. “EW-7197, Transforming Growth Factor β Inhibitor, Combined with Irreversible Electroporation for Improving Skin Wound in a Rat Excisional Model.” Scientific Reports, vol. 14, no. 1, June 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41598-024-61003-8.

APA

Chu Hui Zeng, Jeon Min Kang, Song Hee Kim, Yubeen Park, Soyeon Shim, Dae-Kee Kim, Ji Hoon Shin, & Jung-Hoon Park. (2024). EW-7197, transforming growth factor β inhibitor, combined with irreversible electroporation for improving skin wound in a rat excisional model. Scientific Reports, 14(1), 1–9. https://doi.org/10.1038/s41598-024-61003-8

Chicago

Chu Hui Zeng, Jeon Min Kang, Song Hee Kim, Yubeen Park, Soyeon Shim, Dae-Kee Kim, Ji Hoon Shin, and Jung-Hoon Park. 2024. “EW-7197, Transforming Growth Factor β Inhibitor, Combined with Irreversible Electroporation for Improving Skin Wound in a Rat Excisional Model.” Scientific Reports 14 (1): 1–9. doi:10.1038/s41598-024-61003-8.